Manzo Pharmaceuticals Inc. (MNZO)

[investor_61]

Why would Gerber enter into any kind of arrangement with a Pink Sheet company that has a $2.8M market cap? Makes no sense. If they were interested in the product, they would just buy a controlling interest in the company then sell the patent to themselves for a dollar.

By the same logic, why would Manzo risk losing control of his "valuable" intellectual property, by giving it to a "worthless" public shell?

As an aside, I notice three new directors have been appointed to Manzo's Board (Thomas Morton, Robert Mroczek & Jason Randolph). I wonder why it wasn't announced? If they don't behave like a serious company, how can they expect the Market to take them seriously? I guess the old adage is true: they reap what they sow.